Atlas Trials

Primary Central Nervous System Non-Hodgkin Lymphoma

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Central Nervous System Non-Hodgkin Lymphoma

RecordFirmDate
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma (NCT01973062)Case Comprehensive Cancer Center2014-03-01
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)National Cancer Institute (NCI)2013-06-01
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015)City of Hope Medical Center2012-10-29
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919)National Cancer Institute (NCI)2011-01-01
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274)National Cancer Institute (NCI)2010-06-01
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma (NCT00918333)Mayo Clinic2009-06-01
Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction (NCT00499811)National Cancer Institute (NCI)2007-06-01
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00293345)National Cancer Institute (NCI)2006-06-01
PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00348985)National Cancer Institute (NCI)2006-03-01
MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas (NCT00098891)National Cancer Institute (NCI)2004-10-01
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415)National Cancer Institute (NCI)2001-08-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241)National Cancer Institute (NCI)1999-10-01
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (NCT00003970)National Cancer Institute (NCI)1999-01-01

Track Primary Central Nervous System Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.